Related Experiment Video

Updated: Jun 23, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

Oncostatin M deficiency leads to thymic hypoplasia, accumulation of apoptotic thymocytes and glomerulonephritis

Eiji Esashi1, Hiroaki Ito, Ken-ichi Minehata

  • 1Institute of Molecular and Cellular Biosciences, University of Tokyo Bunkyo-ku, Tokyo, Japan.

European Journal of Immunology
|April 23, 2009
PubMed

Insights

Oncostatin M (OSM) is vital for preventing autoimmune diseases. Its deficiency leads to thymus issues and autoantibody production, suggesting a role in clearing apoptotic thymocytes.

Area of Science:

  • Immunology
  • Autoimmune Diseases
  • Cell Biology

Background:

  • Oncostatin M (OSM) is known to be involved in immune regulation, but its specific functions are not fully understood.
  • The precise role of OSM in the development and prevention of autoimmune conditions requires further elucidation.

Purpose of the Study:

  • To investigate the role of Oncostatin M (OSM) in the development of autoimmune diseases.
  • To determine the mechanisms by which OSM influences immune homeostasis and self-tolerance.

Main Methods:

  • Analysis of OSM-deficient mice, including assessment of immune cell development (T cells, B cells, dendritic cells).
  • Histological examination of thymus structure and evaluation of autoantibody production.
  • Investigation of thymocyte apoptosis and the effects of dexamethasone administration in OSM-deficient mice.

Main Results:

  • OSM-deficient mice exhibited normal immune cell development but showed thymic hypoplasia and altered medullary structure.
  • Aged OSM-deficient mice accumulated autoantibodies against dsDNA and developed glomerulonephritis.
  • Accumulation of apoptotic thymocytes and increased autoantibody production were observed in OSM-deficient mice, particularly after dexamethasone treatment.

Conclusions:

  • Oncostatin M (OSM) plays a critical role in preventing autoimmune diseases.
  • OSM appears to regulate the clearance of apoptotic thymocytes, a mechanism crucial for maintaining self-tolerance and preventing autoimmunity.

More Related Videos

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Related Concept Videos

Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...